Clinical trial
Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in…
NCT00200174 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00200174 |
|---|---|
| Title | Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease |
| Official title | Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease: A Pilot Chemoprevention Trial |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | Pharmacia Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Raloxifene followed by combination therapy, Exemestane followed by combination therapy |
| Enrollment | 11 |
| Start date | Jul 1, 1999 |
| Primary completion | Jul 1, 2003 |
| Completion | Aug 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 5, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: